FDA Warning Wire: Pfizer Lapse Boosts Teva Blockbuster
A newly disclosed warning letter to Pfizer is setting off a chain reaction that will likely delay a generic version of Teva's blockbuster Copaxone, one of the world's best-selling drugs. Here's...To view the full article, register now.
Already a subscriber? Click here to view full article